| A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma C Lertbutsayanukul, A Prayongrat, D Kannarunimit, C Chakkabat, ... Strahlentherapie und Onkologie 194 (5), 375-385, 2018 | 39 | 2018 |
| A randomized phase II/III study of adverse events between sequential (SEQ) versus simultaneous integrated boost (SIB) intensity modulated radiation therapy (IMRT) in … AP Songthong, D Kannarunimit, C Chakkabat, C Lertbutsayanukul Radiation Oncology 10, 1-10, 2015 | 38 | 2015 |
| Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma: a single institutional experience A Prayongrat, C Xu, H Li, SH Lin Advances in Radiation Oncology 2 (3), 301-307, 2017 | 37 | 2017 |
| Selection of external beam radiotherapy approaches for precise and accurate cancer treatment H Shirato, QT Le, K Kobashi, A Prayongrat, S Takao, S Shimizu, A Giaccia, ... Journal of Radiation Research 59 (suppl_1), i2-i10, 2018 | 34 | 2018 |
| Prevalence and significance of plasma Epstein-Barr Virus DNA level in nasopharyngeal carcinoma A Prayongrat, C Chakkabat, D Kannarunimit, P Hansasuta, ... Journal of Radiation Research 58 (4), 509-516, 2017 | 33 | 2017 |
| Validation of previously reported predictors for radiation-induced hypothyroidism in nasopharyngeal cancer patients treated with intensity-modulated radiation therapy, a post … C Lertbutsayanukul, S Kitpanit, A Prayongrat, D Kannarunimit, ... Journal of radiation research 59 (4), 446-455, 2018 | 29 | 2018 |
| Efficacy of intensity-modulated radiotherapy with concurrent carboplatin in nasopharyngeal carcinoma A Songthong, C Chakkabat, D Kannarunimit, C Lertbutsayanukul Radiology and oncology 49 (2), 155-162, 2015 | 26 | 2015 |
| The normal tissue complication probability model-based approach considering uncertainties for the selective use of radiation modality in primary liver cancer patients A Prayongrat, K Kobashi, YM Ito, N Katoh, M Tamura, Y Dekura, ... Radiotherapy and Oncology 135, 100-106, 2019 | 19 | 2019 |
| Optimal plasma pretreatment EBV DNA cut-off point for nasopharyngeal cancer patients treated with intensity modulated radiation therapy C Lertbutsayanukul, D Kannarunimit, B Netsawang, S Kitpanit, ... Japanese Journal of Clinical Oncology 48 (5), 467-475, 2018 | 17 | 2018 |
| Prognostic value of plasma EBV DNA for nasopharyngeal cancer patients during treatment with intensity-modulated radiation therapy and concurrent chemotherapy C Lertbutsayanukul, D Kannarunimit, A Prayongrat, C Chakkabat, ... Radiology and Oncology 52 (2), 195-203, 2018 | 16 | 2018 |
| High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma C Lertbutsayanukul, C Tharavej, N Klaikeaw, A Prayongrat, ... Thoracic Cancer 8 (3), 219-228, 2017 | 16 | 2017 |
| Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients with cervical nodal necrosis M Lan, C Chen, Y Huang, L Tian, Z Duan, F Han, J Liao, M Deng, TT Sio, ... Scientific reports 7 (1), 42624, 2017 | 16 | 2017 |
| Present developments in reaching an international consensus for a model-based approach to particle beam therapy A Prayongrat, K Umegaki, A Van Der Schaaf, AC Koong, SH Lin, ... Journal of radiation research 59 (suppl_1), i72-i76, 2018 | 10 | 2018 |
| Prospective study to evaluate the safety of the world-first spot-scanning dedicated, small 360-degree gantry, synchrotron-based proton beam therapy system K Nishioka, A Prayongrat, K Ono, S Onodera, T Hashimoto, N Katoh, ... Journal of Radiation Research 59 (suppl_1), i63-i71, 2018 | 10 | 2018 |
| Long‐term patient‐rated cosmetic and satisfactory outcomes of early breast cancer treated with conventional versus hypofractionated breast irradiation with simultaneous … C Lertbutsayanukul, M Pitak, N Ajchariyasongkram, N Rakkiet, F Seuree, ... The Breast Journal 26 (10), 1946-1952, 2020 | 9 | 2020 |
| Comparison between the seventh and eighth edition of the AJCC/UICC staging system for nasopharyngeal cancer integrated with pretreatment plasma Epstein–Barr virus DNA level in … S Kitpanit, N Jittapiromsak, A Sriyook, A Prayongrat, D Kannarunimit, ... Japanese Journal of Clinical Oncology 49 (12), 1100-1113, 2019 | 9 | 2019 |
| Tumor prognostic prediction of nasopharyngeal carcinoma using CT-based radiomics in non-Chinese patients S Intarak, Y Chongpison, M Vimolnoch, S Oonsiri, S Kitpanit, A Prayongrat, ... Frontiers in Oncology 12, 775248, 2022 | 8 | 2022 |
| Assessing the uncertainty in a normal tissue complication probability difference (∆ NTCP): radiation-induced liver disease (RILD) in liver tumour patients treated with proton … K Kobashi, A Prayongrat, T Kimoto, C Toramatsu, Y Dekura, N Katoh, ... Journal of Radiation Research 59 (suppl_1), i50-i57, 2018 | 7 | 2018 |
| Outcomes of stereotactic radiosurgery of brain metastases from neuroendocrine tumors A Prayongrat, R Tao, PK Allen, N Guha, G Rao, Z Zhao, J Li, PD Brown, ... Neuro-Oncology Practice 5 (1), 37-45, 2018 | 5 | 2018 |
| Flattening filter free stereotactic body radiation therapy for lung tumors: outcomes and predictive factors T Jaruthien, S Kitpanit, D Kannarunimit, C Nantavithya, A Prayongrat, ... Translational Cancer Research 10 (2), 571, 2021 | 4 | 2021 |
